{"disease":{"id":"osteoporosis-or-bone-loss","name":"osteoporosis or bone loss"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05405894","title":"Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"University of Calgary","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}